Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome

Abstract 18F-FP-CIT is a high-resolution imaging marker of nigrostriatal neuronal integrity, differentiating Parkinsonism with loss of dopaminergic terminals (presynaptic Parkinsonian syndrome [PS]) from Parkinsonism without nigrostriatal degeneration (non-PS). We assessed the diagnostic accuracy of...

Full description

Bibliographic Details
Main Authors: Minyoung Oh, Seung Jun Oh, Sang Ju Lee, Jungsu S. Oh, Sun Ju Chung, Jae Seung Kim
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-42135-9
_version_ 1797452629708636160
author Minyoung Oh
Seung Jun Oh
Sang Ju Lee
Jungsu S. Oh
Sun Ju Chung
Jae Seung Kim
author_facet Minyoung Oh
Seung Jun Oh
Sang Ju Lee
Jungsu S. Oh
Sun Ju Chung
Jae Seung Kim
author_sort Minyoung Oh
collection DOAJ
description Abstract 18F-FP-CIT is a high-resolution imaging marker of nigrostriatal neuronal integrity, differentiating Parkinsonism with loss of dopaminergic terminals (presynaptic Parkinsonian syndrome [PS]) from Parkinsonism without nigrostriatal degeneration (non-PS). We assessed the diagnostic accuracy of 18F-FP-CIT PET in patients with clinically uncertain PS (CUPS) at the first visit. Among the 272 patients who underwent 18F-FP-CIT PET imaging at the first visit between September 2008 and July 2012, 111 had CUPS (age, 62.6 ± 10.5 y; male:female, 45:66; symptom duration, 13.1 ± 8.8 months). Uncertainty criteria included only one of the three cardinal signs of Parkinsonism, two signs without bradykinesia, or atypical signs. The baseline clinical and 18F-FP-CIT PET imaging diagnostic accuracy was compared with the accuracy of clinical diagnosis after > 2-year follow-up. Nuclear medicine physicians assessed the 18F-FP-CIT PET images visually. Focal dopamine transporter binding deficit in the posterior putamen was considered PS. Bilateral symmetric striatum without focal deficit, suggesting normal 18F-FP-CIT PET, and focal deficits elsewhere in the striatum suggesting vascular Parkinsonism were considered non-PS. Seventy-nine patients had PS, and 32 did not. Baseline clinical diagnosis included PS in 45 patients, non-PS in 24, and inconclusive in 42. Among patients in whom initial clinical diagnosis (PS or non-PS) was possible, the sensitivity, specificity, and accuracy of the baseline clinical and 18F-FP-CIT PET imaging diagnoses were 54.4, 50.0, and 53.2%, and 98.7, 100, and 99.1%, respectively. The respective positive and negative predictive values were 95.6 and 66.7%, and 100 and 97.0%. Among those with initially inconclusive diagnosis, 64.2% were eventually diagnosed with PS while 35.7% were diagnosed with non-PS. The final clinical diagnosis of these patients all matched those made by 18F-FP-CIT PET imaging, except in one patient with scan without evidence of dopaminergic deficit (SWEDD). 18F-FP-CIT PET diagnosis was more accurate than clinical diagnosis, reducing the false-negative and inconclusive clinical diagnosis rates at baseline in patients with CUPS.
first_indexed 2024-03-09T15:11:25Z
format Article
id doaj.art-13fbcc4f1aa04a3ca05a9cee3ee4dded
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-09T15:11:25Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-13fbcc4f1aa04a3ca05a9cee3ee4dded2023-11-26T13:21:18ZengNature PortfolioScientific Reports2045-23222023-09-011311710.1038/s41598-023-42135-9Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndromeMinyoung Oh0Seung Jun Oh1Sang Ju Lee2Jungsu S. Oh3Sun Ju Chung4Jae Seung Kim5Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineAbstract 18F-FP-CIT is a high-resolution imaging marker of nigrostriatal neuronal integrity, differentiating Parkinsonism with loss of dopaminergic terminals (presynaptic Parkinsonian syndrome [PS]) from Parkinsonism without nigrostriatal degeneration (non-PS). We assessed the diagnostic accuracy of 18F-FP-CIT PET in patients with clinically uncertain PS (CUPS) at the first visit. Among the 272 patients who underwent 18F-FP-CIT PET imaging at the first visit between September 2008 and July 2012, 111 had CUPS (age, 62.6 ± 10.5 y; male:female, 45:66; symptom duration, 13.1 ± 8.8 months). Uncertainty criteria included only one of the three cardinal signs of Parkinsonism, two signs without bradykinesia, or atypical signs. The baseline clinical and 18F-FP-CIT PET imaging diagnostic accuracy was compared with the accuracy of clinical diagnosis after > 2-year follow-up. Nuclear medicine physicians assessed the 18F-FP-CIT PET images visually. Focal dopamine transporter binding deficit in the posterior putamen was considered PS. Bilateral symmetric striatum without focal deficit, suggesting normal 18F-FP-CIT PET, and focal deficits elsewhere in the striatum suggesting vascular Parkinsonism were considered non-PS. Seventy-nine patients had PS, and 32 did not. Baseline clinical diagnosis included PS in 45 patients, non-PS in 24, and inconclusive in 42. Among patients in whom initial clinical diagnosis (PS or non-PS) was possible, the sensitivity, specificity, and accuracy of the baseline clinical and 18F-FP-CIT PET imaging diagnoses were 54.4, 50.0, and 53.2%, and 98.7, 100, and 99.1%, respectively. The respective positive and negative predictive values were 95.6 and 66.7%, and 100 and 97.0%. Among those with initially inconclusive diagnosis, 64.2% were eventually diagnosed with PS while 35.7% were diagnosed with non-PS. The final clinical diagnosis of these patients all matched those made by 18F-FP-CIT PET imaging, except in one patient with scan without evidence of dopaminergic deficit (SWEDD). 18F-FP-CIT PET diagnosis was more accurate than clinical diagnosis, reducing the false-negative and inconclusive clinical diagnosis rates at baseline in patients with CUPS.https://doi.org/10.1038/s41598-023-42135-9
spellingShingle Minyoung Oh
Seung Jun Oh
Sang Ju Lee
Jungsu S. Oh
Sun Ju Chung
Jae Seung Kim
Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
Scientific Reports
title Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
title_full Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
title_fullStr Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
title_full_unstemmed Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
title_short Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
title_sort diagnostic accuracy of 18f fp cit pet for clinically uncertain parkinsonian syndrome
url https://doi.org/10.1038/s41598-023-42135-9
work_keys_str_mv AT minyoungoh diagnosticaccuracyof18ffpcitpetforclinicallyuncertainparkinsoniansyndrome
AT seungjunoh diagnosticaccuracyof18ffpcitpetforclinicallyuncertainparkinsoniansyndrome
AT sangjulee diagnosticaccuracyof18ffpcitpetforclinicallyuncertainparkinsoniansyndrome
AT jungsusoh diagnosticaccuracyof18ffpcitpetforclinicallyuncertainparkinsoniansyndrome
AT sunjuchung diagnosticaccuracyof18ffpcitpetforclinicallyuncertainparkinsoniansyndrome
AT jaeseungkim diagnosticaccuracyof18ffpcitpetforclinicallyuncertainparkinsoniansyndrome